1. State of the TB Alliance
Mel Spigelman SHA Meeting 28 October 2013 Paris, France

2. 2013 – A Year of Accelerated Progress
Pediatric TB
No longer the neglected of the neglected
Market Access
Preparing for impact
Research & Development
Universal regimens closer to reality
Resource Mobilization

3. TB Alliance Funders United States Agency for International Development
Bill & Melinda Gates Foundation
UNITAID
UK aid
United States
Food and Drug Administration
National Institute of Allergy and Infectious Disease
AIDS Clinical
Trial Group
European
Commission
Global Health Innovative Technology Fund
Australian AID
Irish Aid
TB Alliance Overview

4. 2014 – A Year of Accelerated Partnerships
Market Access
Government agencies (NTPs, regulatory authorities, MOH,…)
WHO
NGOs – “on the ground” implementers
Manufacturers, distributors
Research & Development
Enhanced clinical trial capacity and decreased clinical trial costs
Enhanced coordination – data and compound sharing, clinical trial planning
Funding
Partnering along entire value chain
Greater involvement of middle income countries
“Consortia” funding of most expensive initiatives